How Sleep Apnea Affects Your Health Beyond Sleep

Obstructive sleep apnea is typically diagnosed, treated, and discussed as a sleep disorder. That framing, while technically accurate, understates what the condition actually does to the body. Each apnea event — a partial or complete airway collapse lasting seconds to more than a minute — triggers a cascade of physiological responses: a brief drop in blood oxygen, a surge of sympathetic nervous system activity, a cortisol spike, a microarousal that fragments sleep architecture. When this happens five to thirty times an hour, every hour, night after night, the cumulative biological load is substantial and wide-ranging. "Sleep apnea is a cardiovascular disease, a metabolic disease, and a brain disease," says Dr. Rachel Simone, a sleep researcher at the Stanford Center for Sleep Sciences and Medicine. "We just happen to diagnose it by looking at sleep."

The mechanism: what happens inside during an apnea event

To understand sleep apnea's systemic effects, it helps to understand what physiologically occurs during an apnea episode. As the airway collapses, airflow ceases. Blood oxygen saturation begins to fall — in severe cases dropping below 80 percent from a normal resting level above 95 percent. The brain detects the hypoxia and triggers a sympathetic nervous system response: adrenaline and cortisol are released, heart rate increases, blood pressure spikes, and the sleeper briefly arouses to reopen the airway. The arousal is typically too brief to reach conscious awareness but sufficient to fragment sleep architecture.

In moderate-to-severe OSA, this cycle repeats fifteen to sixty or more times per hour across the entire night. The cumulative effect is chronic intermittent hypoxia — a pattern of repeated oxygen deprivation and reoxygenation that, over months and years, produces oxidative stress and inflammation in virtually every organ system the bloodstream reaches. "The repeated hypoxia-reoxygenation cycle is more damaging than sustained hypoxia at the same average oxygen level," says Dr. James Whitfield, a pulmonologist and sleep medicine specialist at Cleveland Clinic. "The oscillation generates reactive oxygen species and activates inflammatory pathways in a way that continuous low oxygen doesn't."

Cardiovascular consequences

The cardiovascular system bears the most heavily documented burden of untreated OSA.

Hypertension

The association between OSA and high blood pressure is among the strongest in sleep medicine. Studies estimate that 30 to 50 percent of patients with hypertension have undiagnosed OSA. The repeated nocturnal sympathetic surges from apnea events elevate nighttime blood pressure and, over time, prevent the normal 10 to 20 percent blood pressure dip that should occur during sleep — a pattern called "non-dipping" that is independently associated with cardiovascular risk. The Joint National Committee on Hypertension lists OSA as the most common identifiable cause of secondary hypertension. Effective treatment with CPAP has been shown to reduce mean blood pressure by 2 to 3 mmHg — modest individually, but clinically meaningful at the population level.

Atrial fibrillation

The relationship between OSA and atrial fibrillation (AFib) is increasingly considered bidirectional. OSA is present in an estimated 25 to 50 percent of AFib patients — a prevalence far above population rates. The proposed mechanisms include hypoxia-induced atrial stretch, autonomic dysregulation, and inflammatory remodeling of atrial tissue. A 2013 study in JACC found that OSA patients who were not treated with CPAP had a significantly higher rate of AFib recurrence after cardioversion or ablation compared to those who were treated. Cardiologists now routinely screen for OSA in AFib patients before and after ablation procedures.

Stroke and heart attack

Prospective cohort data consistently show elevated stroke and myocardial infarction risk in untreated OSA. A landmark 2005 study in the New England Journal of Medicine found that severe untreated OSA was associated with a three-fold increase in fatal and nonfatal cardiovascular events compared to matched controls without OSA. The risk was substantially attenuated in patients effectively treated with CPAP. The mechanisms — hypertension, coagulation activation, endothelial dysfunction, and atherosclerotic acceleration from chronic inflammation — are multiple and mutually reinforcing.

Metabolic consequences

Insulin resistance and type 2 diabetes

The relationship between OSA and metabolic dysfunction is independent of obesity — a crucial point given that obesity and OSA frequently coexist. Even controlling for BMI, OSA is associated with insulin resistance and impaired glucose tolerance. The mechanisms include cortisol excess (which promotes gluconeogenesis and impairs peripheral insulin action), sympathetic activation (which suppresses pancreatic insulin secretion), and fragmentation of slow-wave sleep (during which growth hormone release — an insulin-sensitizing signal — normally peaks).

A 2010 analysis of the Sleep Heart Health Study, a large prospective cohort, found that OSA severity was independently associated with impaired fasting glucose and diabetes prevalence after adjustment for BMI, waist circumference, and age. A subsequent trial found that CPAP treatment improved insulin sensitivity in OSA patients within three months, with greater effect in those with more severe baseline disease.

Weight and the metabolic cycle

OSA and obesity exist in a particularly vicious bidirectional relationship. Excess adipose tissue around the upper airway directly worsens OSA. But OSA also promotes weight gain: sleep fragmentation elevates ghrelin (the hunger hormone) and suppresses leptin (the satiety hormone), increasing caloric intake; cortisol excess promotes visceral fat deposition; and daytime fatigue reduces physical activity. Patients with severe OSA can be caught in a cycle where each condition actively worsens the other. Treating the sleep apnea alone is not sufficient to break this cycle, but it removes one of its driving forces.

Cognitive and neurological consequences

The brain is acutely sensitive to oxygen supply. Repeated nocturnal hypoxia, over years, produces detectable structural and functional changes in brain tissue — particularly in regions associated with memory consolidation and executive function.

Memory and cognitive performance

Slow-wave sleep is the stage in which the brain consolidates declarative memories — the events, facts, and experiences that form episodic memory. OSA disrupts slow-wave sleep architecture significantly. Studies using neuropsychological testing consistently show that OSA patients perform worse than matched controls on tasks requiring attention, working memory, and processing speed. A 2014 study in JAMA Neurology found that patients with moderate-to-severe OSA exhibited hippocampal volume reduction comparable to that seen in early cognitive decline.

Dementia risk

The glymphatic system — a network of perivascular channels that clears metabolic waste from the brain during sleep, including amyloid-beta and tau protein — is most active during slow-wave sleep. OSA significantly disrupts slow-wave sleep, impairing this clearance mechanism. Observational studies have found that OSA patients have higher rates of amyloid accumulation and elevated dementia risk. A 2023 meta-analysis estimated that OSA was associated with a 26 percent increased risk of dementia, with greater risk in patients with more severe disease. Whether CPAP treatment meaningfully reduces long-term dementia risk remains an active area of research; the mechanistic case is strong, but randomized trial data are still emerging.

Mental health consequences

The relationship between OSA and mental health is complex and bidirectional. Depression is approximately twice as prevalent in OSA patients as in matched controls. Anxiety disorders are similarly elevated. The mechanisms include direct effects of chronic sleep disruption on mood regulation, the neurobiological consequences of intermittent hypoxia on serotonin and dopamine systems, and the secondary psychological effects of persistent fatigue, cognitive fog, and reduced quality of life.

"A significant proportion of patients I see who are being treated for depression without improvement have undiagnosed sleep apnea," says Whitfield. "Treating the OSA doesn't always resolve the depression — the relationship is bidirectional and complicated — but for some patients, treating the sleep disorder is what allows the antidepressant to work."

What treatment actually reverses

The body of evidence on treatment outcomes is, in aggregate, encouraging. Effective treatment of OSA — whether through CPAP, oral appliances, or surgical intervention — produces measurable improvements across most of the systemic domains affected by the disease:

• Blood pressure: Modest but consistent reductions (2–3 mmHg mean), with larger effects in patients with severe OSA and drug-resistant hypertension
• Glycemic control: Improvements in insulin sensitivity and HbA1c in patients with comorbid type 2 diabetes
• Atrial fibrillation: Reduced recurrence rates after ablation in patients adherent to CPAP
• Mood and depression: Clinically significant improvement in depressive symptom scores in several controlled trials
• Cognitive function: Improvements in attention, memory, and processing speed, particularly in patients diagnosed and treated earlier

The most important variable is treatment adherence. CPAP produces these benefits only when used consistently — the approximately 40 to 50 percent of patients who don't use their machines regularly do not accrue them. This is part of why the choice of treatment modality matters: an oral appliance used every night may produce better real-world cardiovascular outcomes than a CPAP machine used half the time.

Frequently asked questions

What health problems does untreated sleep apnea cause?

Untreated OSA is associated with hypertension, atrial fibrillation, elevated stroke and heart attack risk, insulin resistance and type 2 diabetes, cognitive impairment, dementia risk, depression, anxiety, and sexual dysfunction. These effects are produced by chronic intermittent hypoxia, repeated sympathetic nervous system activation, cortisol excess, and fragmentation of restorative slow-wave and REM sleep.

Can sleep apnea cause a heart attack?

Untreated moderate-to-severe OSA is associated with significantly elevated cardiovascular event risk. A landmark NEJM cohort study found severe untreated OSA was associated with a three-fold increase in fatal and nonfatal cardiovascular events. The mechanisms — hypertension, coagulation activation, endothelial dysfunction, accelerated atherosclerosis — are well-established. Effective treatment reduces but does not fully eliminate this excess risk.

Does sleep apnea cause weight gain?

OSA promotes weight gain through several mechanisms: elevated ghrelin and suppressed leptin (increasing hunger and reducing satiety), cortisol excess (promoting visceral fat accumulation), and fatigue-driven reduction in physical activity. This creates a bidirectional cycle in which obesity worsens OSA and OSA promotes further weight gain. Treating OSA does not directly produce weight loss, but it removes one of the biological drivers of the cycle and can improve responsiveness to weight management interventions.

Can treating sleep apnea improve my overall health?

Yes — across multiple domains. Controlled trials and large cohort studies show effective OSA treatment produces measurable reductions in blood pressure, improvements in insulin sensitivity and glycemic control, lower atrial fibrillation recurrence rates, and significant improvements in depression scores and cognitive performance. The magnitude of benefit is generally proportional to disease severity and treatment adherence.

How do I know if I have sleep apnea if I don't have a bed partner to report snoring?

Many people with OSA don't know about their snoring or gasping. Common symptoms that don't require a bed partner include: waking with headaches or a dry mouth; persistent daytime fatigue despite adequate sleep time; difficulty concentrating; irritability or mood changes; and waking with a sensation of not having rested. An at-home sleep test can confirm or rule out OSA without an in-lab overnight study — see our guide to at-home sleep testing for more detail.